The LINC00612/miR-331-3p/SOCS1 axis mediates the cardioprotective effect of sevoflurane against myocardial ischemia-reperfusion injury
Archives of Biochemistry and Biophysics · 2026-07 · 781 · 110803
DOI: 10.1016/j.abb.2026.110803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-07. Verfasst von Yu Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Yueqing Hospital of Wenzhou Medical University, Yueqing City, Zhejiang, 325600, China. Hauptthemen laut MEDLINE: Sevoflurane, MicroRNAs, RNA, Long Noncoding, Myocardial Reperfusion Injury. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Myocardial ischemia-reperfusion injury (MIRI) represents a critical pathological challenge in cardiovascular disease treatment. Sevoflurane (Sev) preconditioning has been demonstrated to effectively mitigate MIRI, yet its specific molecular mechanism remains incompletely elucidated. AIM: This study aims to investigate whether Sev preconditioning exerts myocardial protection by regulating the LINC00612/miR-331-3p/SOCS1 axis. METHODS: AC16 cells were used to establish an H/R model to simulate MIRI, with pretreatment by Sev. RT-qPCR was used to detect the expression of LINC00612, miR-331-3p, and SOCS1 in cells. Cell viability and apoptosis were assessed by CCK8 assay and flow cytometry. Cardiac injury markers cTnⅠ and CK-MB, pro-inflammatory cytokines IL-6 and TNF-α, and oxidative stress markers MDA and SOD were detected by ELISA and related kits. The protein levels of SOCS1, Bax/Bcl-2, and p-STAT1/p-STAT3 were detected by Western blot. Dual-luciferase reporter assays were employed to identify the binding of miR-331-3p to LINC00612 and SOCS1. RESULTS: H/R treatment reduced LINC00612 expression, while Sev pretreatment upregulated its expression. Sev preconditioning enhanced cell viability, inhibited apoptosis, and mitigated myocardial injury and inflammatory cytokine release, whereas silencing LINC00612 counteracted these protective effects. However, inhibition of miR-331-3p reversed cell injury caused by silencing LINC00612. Additionally, SOCS1 was found to have a direct targeting relationship with miR-331-3p. CONCLUSION: Sev preconditioning may mitigate MIRI by modulating apoptosis, oxidative stress, and inflammatory responses through regulation of the LINC00612/miR-331-3p/SOCS1 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Affiliated Yueqing Hospital of Wenzhou Medical University, Yueqing City, Zhejiang, 325600, China.
- Qingdao Special Service Sanatorium of PLA Navy, Qingdao City, Shandong, China.
- Department of Anesthesiology, University-town Hospital of Chongqing Medical University, Chongqing, 401331, China. Electronic address: Gangouoo@163.com.
Zitieren
APA
Lin, Y., Liu, J., & Ou, G. (2026). The LINC00612/miR-331-3p/SOCS1 axis mediates the cardioprotective effect of sevoflurane against myocardial ischemia-reperfusion injury. Archives of Biochemistry and Biophysics, 781, 110803. https://doi.org/10.1016/j.abb.2026.110803
Vancouver
Lin Y, Liu J, Ou G. The LINC00612/miR-331-3p/SOCS1 axis mediates the cardioprotective effect of sevoflurane against myocardial ischemia-reperfusion injury. Archives of Biochemistry and Biophysics. 2026;781:110803. doi:10.1016/j.abb.2026.110803
BibTeX
@article{Lin2026,
author = {Lin, Yu and Liu, Jihong and Ou, Gang},
title = {The LINC00612/miR-331-3p/SOCS1 axis mediates the cardioprotective effect of sevoflurane against myocardial ischemia-reperfusion injury},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
volume = {781},
pages = {110803},
doi = {10.1016/j.abb.2026.110803}
}
EUVIMED